115 related articles for article (PubMed ID: 11897629)
1. rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease.
Byrne FR; Farrell CL; Aranda R; Rex KL; Scully S; Brown HL; Flores SA; Gu LH; Danilenko DM; Lacey DL; Ziegler TR; Senaldi G
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G690-701. PubMed ID: 11897629
[TBL] [Abstract][Full Text] [Related]
2. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
3. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.
Rao VP; Poutahidis T; Ge Z; Nambiar PR; Horwitz BH; Fox JG; Erdman SE
Cancer Res; 2006 Jan; 66(1):57-61. PubMed ID: 16397216
[TBL] [Abstract][Full Text] [Related]
5. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin.
Byrne FR; Morony S; Warmington K; Geng Z; Brown HL; Flores SA; Fiorino M; Yin SL; Hill D; Porkess V; Duryea D; Pretorius JK; Adamu S; Manoukian R; Danilenko DM; Sarosi I; Lacey DL; Kostenuik PJ; Senaldi G
Gut; 2005 Jan; 54(1):78-86. PubMed ID: 15591508
[TBL] [Abstract][Full Text] [Related]
8. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
[TBL] [Abstract][Full Text] [Related]
9. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.
Khalil PN; Weiler V; Nelson PJ; Khalil MN; Moosmann S; Mutschler WE; Siebeck M; Huss R
Gastroenterology; 2007 Mar; 132(3):944-54. PubMed ID: 17383423
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
11. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
[TBL] [Abstract][Full Text] [Related]
12. Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.
Kim N; Kunisawa J; Kweon MN; Eog Ji G; Kiyono H
Clin Immunol; 2007 Apr; 123(1):30-9. PubMed ID: 17218154
[TBL] [Abstract][Full Text] [Related]
13. T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice.
Dohi T; Fujihashi K; Koga T; Shirai Y; Kawamura YI; Ejima C; Kato R; Saitoh K; McGhee JR
Gastroenterology; 2003 Mar; 124(3):672-82. PubMed ID: 12612906
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis.
Miceli R; Hubert M; Santiago G; Yao DL; Coleman TA; Huddleston KA; Connolly K
J Pharmacol Exp Ther; 1999 Jul; 290(1):464-71. PubMed ID: 10381813
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.
Dalmasso G; Cottrez F; Imbert V; Lagadec P; Peyron JF; Rampal P; Czerucka D; Groux H; Foussat A; Brun V
Gastroenterology; 2006 Dec; 131(6):1812-25. PubMed ID: 17087945
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease.
Ding X; Hiraku Y; Ma N; Kato T; Saito K; Nagahama M; Semba R; Kuribayashi K; Kawanishi S
Cancer Sci; 2005 Mar; 96(3):157-63. PubMed ID: 15771618
[TBL] [Abstract][Full Text] [Related]
17. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Aharoni R; Kayhan B; Brenner O; Domev H; Labunskay G; Arnon R
J Pharmacol Exp Ther; 2006 Jul; 318(1):68-78. PubMed ID: 16624971
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.
Leach MW; Bean AG; Mauze S; Coffman RL; Powrie F
Am J Pathol; 1996 May; 148(5):1503-15. PubMed ID: 8623920
[TBL] [Abstract][Full Text] [Related]
20. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
